Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07036666 · ClinicalTrials.gov registry record · NA
A Study Assessing the Impact of a Women's Health Formulation on Vaginal Health and the Microbial Community
A NA study, sponsored by Radicle Science.
- Completed
- Registry status
- NA
- Development phase
- 500
- Enrollment target
NCT07036666: Completed NA study, sponsored by Radicle Science.
NCT07036666 is a NA study that has completed, run by Radicle Science. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07036666, a NA study, has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
Study Summary
An open label study assessing the impact of a women's health formulation on vaginal health and the microbial community
Primary Outcome
Difference between rates of change over time in vaginal health score as assessed by Vaginal Health Survey (scale 6-30; where the higher scores correspond to worse vaginal health)
Interventions
- DIETARY_SUPPLEMENT Active Product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-07-08 |
| Est. Completion | 2025-10-02 |
| Phase | NA |
What the finished NCT07036666 record still lists
NCT07036666 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 1 intervention - of which Active Product is the first listed.
NCT07036666 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07036666 about?
NCT07036666 is a clinical study titled "A Study Assessing the Impact of a Women's Health Formulation on Vaginal Health and the Microbial Community". An open label study assessing the impact of a women's health formulation on vaginal health and the microbial community
What is the current status of trial NCT07036666?
This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2025-07-08. Estimated completion is 2025-10-02.
What interventions are being tested in trial NCT07036666?
The interventions under investigation include: Active Product (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07036666?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07036666's enrollment target sits among peer trials
500 193rd of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI